The HPV vaccine risks / efficacy could be determined
By Hicbd
Fri Jun 9 2023 11:43 am
"Vaccinating adults age 26 and older against the human papillomavirus (HPV)—the virus that causes more than 90% of cervical cancers as well as several other cancers—may not be cost-effective, according to a new study led by researchers at the Harvard T.H. School of Public Health."
URL:----------------------------------------------------------
Please login to comment